Center-Authored Papers

Filters: Author is Wald, Anna  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Kim HN, Wald A, Harris J, Almekinder J, Heitman C, Corey L.  2008.  Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study. Sexually transmitted diseases. 35(2):124-8. Abstract
Koelle DM, Magaret AS, McClurkan CL, Remington ML, Warren T, Teofilovici F, Wald A.  2008.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.. Clinical and vaccine immunology : CVI. 15(5):773-82. Abstract
Guanira JV, Casper C, Lama JR, Morrow RA, Montano SM, Caballero P, Suárez L, Whittington WLH, Wald A, Sanchez J et al..  2008.  Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.. Journal of acquired immune deficiency syndromes (1999). 49(5):557-62. Abstract
Mark KE, Wald A, Drolette L, Golden MR.  2008.  Internet and email use among STD clinic patients.. Sexually transmitted diseases. 35(11):960-5. Abstract
Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang M-L, Wald A.  2008.  Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.. The Journal of infectious diseases. 198(1):23-30. Abstract
Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L.  2008.  Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.. PloS one. 3(5):e2230. Abstract
Nguyen HQ, Magaret AS, Kitahata MM, Van Rompaey SE, Wald A, Casper C.  2008.  Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.. AIDS (London, England). 22(8):937-45. Abstract
Wloch MK, Smith LR, Boutsaboualoy S, Reyes L, Han C, Kehler J, Smith HD, Selk L, Nakamura R, Brown JM et al..  2008.  Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.. The Journal of infectious diseases. 197(12):1634-42. Abstract
Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang M-L, Corey L.  2008.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.. The Journal of infectious diseases. 198(8):1141-9. Abstract
2009
Gardella C, Krantz E, Daruthayan C, Drolette L, Corey L, Wald A.  2009.  The acceptance of HSV-testing partners of HSV-2 seronegative pregnant women.. Sexually transmitted diseases. 36(4):211-5. Abstract
Peng T, Zhu J, Klock A, Phasouk K, Huang M-L, Koelle DM, Wald A, Corey L.  2009.  Evasion of the mucosal innate immune system by herpes simplex virus type 2.. Journal of virology. 83(23):12559-68. Abstract
Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret AS, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A et al..  2009.  Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.. PloS one. 4(4):e5272. Abstract
Leung DT, Henning PA, Wagner EC, Blasig A, Wald A, Sacks SL, Corey L, Money DM.  2009.  Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy.. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC. 31(12):1137-43. Abstract
Scott JD, Wald A, Kitahata M, Krantz E, Drolette L, Corey L, Wang CC.  2009.  Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.. AIDS patient care and STDs. 23(11):925-9. Abstract
Zuckerman RA, Lucchetti A, Whittington WLH, Sánchez J, Coombs RW, Magaret AS, Wald A, Corey L, Celum C.  2009.  HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.. AIDS (London, England). 23(4):479-83. Abstract
Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret AS, Koelle DM, Wald A et al..  2009.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.. Nature medicine. 15(8):886-92. Abstract
Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang M-L et al..  2009.  Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.. PloS one. 4(1):e4222. Abstract
Corey L, Wald A.  2009.  Maternal and neonatal herpes simplex virus infections.. The New England journal of medicine. 361(14):1376-85.
Martin ET, Taylor J, Kuypers J, Magaret AS, Wald A, Zerr D, Englund JA.  2009.  Detection of bocavirus in saliva of children with and without respiratory illness.. Journal of clinical microbiology. 47(12):4131-2. Abstract
Berrington WR, Jerome KR, Cook L, Wald A, Corey L, Casper C.  2009.  Clinical correlates of herpes simplex virus viremia among hospitalized adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 49(9):1295-301. Abstract
Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret AS, Wald A, Corey L.  2009.  Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.. Science translational medicine. 1(7):7ra16. Abstract
2010
Holtzheimer PE, Veitengruber J, Wang CC, Krows M, Thiede H, Wald A, Roy-Byrne P.  2010.  Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.. General hospital psychiatry. 32(4):426-32. Abstract
Alsallaq RA, Schiffer JT, Longini IM, Wald A, Corey L, Abu-Raddad LJ.  2010.  Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.. Sexually transmitted diseases. 37(5):290-7. Abstract
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E et al..  2010.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.. Lancet. 375(9717):824-33. Abstract
Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C et al..  2010.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.. PloS one. 5(9):e12598. Abstract